ММВБ 3 080 0,9%  Nasdaq 11 043 0,3%  Биткойн 11 725 -0,5%  USD/RUB 72,9905 0,0% 
РТС 1 326 1,5%  S&P500 3 373 -0,2%  Нефть 45,0 -0,3%  EUR/RUB 86,1745 -0,1% 
Dow 27 897 -0,3%  FTSE100 6 186 -1,5%  Золото 1 950 -0,2%  EUR/USD 1,1805 -0,1% 

Курс акций Abbott Laboratories [ISIN: US0028241000]

купить
продать

Abbott Laboratories - Профиль

Abbott Laboratories (Abbott) – основанная в 1888 году глобальная компания, работающая в сфере здравоохранения. Занимается производством оборудования для диагностики и лечения заболеваний, производством лечебного и детского питания и лекарств. Около 30% выручки приходится на США, 30% – на Западную Европу, Канаду, Японию и Австралию, 40% – развивающиеся рынки. В 2013 году завершила выделение исследовательского фармацевтического подразделения в отдельную фирму AbbVie.

Акционеры

Название Доля (%)
Freefloat99,15
Vanguard Group, Inc. (Subfiler)8,35
The Vanguard Group, Inc.8,05
Capital Research & Management Co. (Global Investors)6,40
State Street Corp.4,11
Vanguard Total Stock Market Index Fund2,85
Capital Research & Management Co. (International Investors)2,60
BlackRock Fund Advisors2,48
BlackRock Institutional Trust Co. NA2,40
Wellington Management Co. LLP2,30
Vanguard 500 Index Fund2,07
American Funds Investment Company of America1,74
Northern Trust Corp.1,49
Fidelity Management & Research Co. LLC1,42
Geode Capital Management LLC1,40

Адрес

100 Abbott Park Road, 60064-6400 Abbott Park
а/я:
Телефон: +1 (224) 667-6100
Факс:
Вэб: http://www.abbott.com

Менеджмент

Gene Huang
Chief Economist & Vice President
Robert E. Funck
Chief Financial Officer & Executive Vice President
Miles D. White
Executive Chairman
Mary K. Moreland
Executive Vice President-Human Resources
Lisa D. Earnhardt
Executive Vice President-Medical Devices
Daniel Gesua Sive Salvadori
Executive Vice President-Nutritional Products
John M. Capek
Executive Vice President-Ventures
Darren W. McDew
Independent Director
John G. Stratton
Independent Director
Roxanne Schuh Austin
Independent Director
Glenn Fletcher Tilton
Independent Director
Sally E. Blount
Independent Director
Daniel J. Starks
Independent Director
Nancy McKinstry
Independent Director
Phebe N. Novakovic
Independent Director
Samuel C. Scott
Independent Director
Edward Michael Liddy
Independent Director
Michelle A. Kumbier
Independent Director
Robert J. Alpern
Independent Director
William A. Osborn
Lead Independent Director
Jim Leffelman
Manager-Expense Reporting
Robert B. Ford
President, CEO, Chief Operating Officer & Director
Hubert L. Allen
Secretary, Executive VP & General Counsel
Karen M. Peterson
Treasurer & Vice President
Kathryn S. Collins
Vice President-Commercial Legal Operations
Philip P. Boudreau
Vice President-Finance & Controller
Randel William Woodgrift
Vice President-Global Operations & Cardiovascular
David P. Mark
Vice President-Internal Audit
Scott Leinenweber
Vice President-Investor Relations

Добавить или редактировать инструмент